PARIS (Reuters) – European medical cannabis company EMMAC announced on Monday a research partnership with UK biotechnology company Hyris Limited to develop a library of genetic profiles of existing cannabis varieties.
Earlier this month, EMMAC bought French hemp-based and cannabis healthcare company GreenLeaf, as the legal use of cannabis for medicinal purposes steadily increases.
Cannabis stocks have been a growing trend on world stock markets, particularly on the Toronto stock exchange after Canada became one of the first major economies to legalize the recreational use of marijuana.
0 comments
Share
